These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3651338)

  • 21. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
    Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
    Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo mobilization of polymorphonuclear leukocytes in psoriasis: relationship to clinical parameters and serum inhibitory factors.
    Tigalonowa M; Glinski W; Jablonska S
    J Invest Dermatol; 1983 Jul; 81(1):6-9. PubMed ID: 6863981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diclofenac sodium, a negative chemokinetic factor for neutrophil locomotion.
    Perianin A; Gougerot-Pocidalo MA; Giroud JP; Hakim J
    Biochem Pharmacol; 1985 Oct; 34(19):3433-8. PubMed ID: 3902025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotaxis, spreanding nd oxidative metabolism of neutrophils: influence of albumin in vitro.
    Valerius NH
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):43-9. PubMed ID: 6306991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphonuclear leukocyte function in psoriasis vulgaris.
    Csató M; Dobozy A; Hunyadi J; Simon N
    Dermatol Monatsschr; 1983 Apr; 169(4):238-42. PubMed ID: 6345228
    [No Abstract]   [Full Text] [Related]  

  • 27. Bovine peripheral blood polymorphonuclear neutrophil chemotactic response to Pasteurella haemolytica or zymosan-activated serum.
    Bruecker KA; Schwartz LW
    Am J Vet Res; 1982 Oct; 43(10):1879-81. PubMed ID: 7149395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotaxis in yersinia arthritis. In vitro stimulation of neutrophil migration by HLA--B27 positive and negative sera.
    Repo H; Leirisalo M; Tiilikainen A; Laitinen O
    Arthritis Rheum; 1982 Jun; 25(6):655-61. PubMed ID: 6980007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate inhibits polymorphonuclear leucocyte chemotaxis in psoriasis.
    Walsdorfer U; Christophers E; Schröder JM
    Br J Dermatol; 1983 Apr; 108(4):451-6. PubMed ID: 6838769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocyte migration in vivo and in vitro in patients with psoriasis.
    Scheja A; Bruze M; Forsgren A
    Acta Derm Venereol; 1987; 67(5):427-32. PubMed ID: 2448995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis.
    Silny W; Pehamberger H; Zielinsky C; Gschnait F
    J Invest Dermatol; 1980 Aug; 75(2):187-8. PubMed ID: 6893337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of neutrophils function as a result of prior exposure to chemotactic factor.
    Van Epps DE; Garcia ML
    J Clin Invest; 1980 Aug; 66(2):167-75. PubMed ID: 6249846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
    Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
    J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphonuclear leukocyte chemotaxis in generalized pustular psoriasis.
    Zelickson BD; Pittelkow MR; Muller SA; Johnson CM
    Acta Derm Venereol; 1987; 67(4):326-30. PubMed ID: 2445152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors.
    Fletcher MP; Stahl GL; Longhurst JC
    J Leukoc Biol; 1990 Apr; 47(4):355-65. PubMed ID: 2108228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone.
    Perianin A; Labro MT; Hakim J
    Biochem Pharmacol; 1982 Oct; 31(19):3071-6. PubMed ID: 6756410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired motility of neonatal PMN leukocytes: relationship to abnormalities of cell orientation and assembly of microtubules in chemotactic gradients.
    Anderson DC; Hughes BJ; Wible LJ; Perry GJ; Smith CW; Brinkley BR
    J Leukoc Biol; 1984 Jul; 36(1):1-15. PubMed ID: 6376671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired chemotaxis and neutrophil (polymorphonuclear leukocyte) function in glycogenosis type IB.
    Koven NL; Clark MM; Cody CS; Stanley CA; Baker L; Douglas SD
    Pediatr Res; 1986 May; 20(5):438-42. PubMed ID: 3459131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neutrophil granulocyte chemotaxis and psoriasis].
    Christophers E; Schröder JM
    Hautarzt; 1981 Nov; 32(11):558-63. PubMed ID: 6458581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volume dependent polymorphonuclear leukocytes fractions isolated by counterflow centrifugal elutriation: PMN volume does not correlate with PMN age.
    Berkow RL; Dodson RW
    J Leukoc Biol; 1987 Jun; 41(6):518-26. PubMed ID: 3036985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.